David W Hein

32PUBLICATIONS
40CO-AUTHORS
Haematological tumoursCancer diagnosisNanomedicineReaction engineering (excl. nuclear reactions)Empirical software engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|May 04, 2026
Impact of N-Acetylation on DNA Damage and Oxidative Stress Responses in Mammalian Cells and Human Hepatocytes Treated with Hydralazine.

|Feb 28, 2026
Impact of the University of Louisville Cancer Education Program.

LaCreis R Kidd, Luz Huntington-Moskos, David W Hein

|Dec 23, 2025
PharmVar GeneFocus: NAT2-Genetic Variation and Updated Nomenclature.

Georgia Papanikolaou, Estella S Poloni, José A G Agúndez

|Dec 08, 2025
Correction: Effect of N‑acetyltransferase 2 genetic polymorphism on 4,4'‑methylenebis(2‑chloroaniline)‑induced genotoxicity and oxidative stress.

Mariam R Habil, Raúl A Salazar-González, Mark A Doll

|Sep 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.

Michael T Eadon, David W Hein, Michael A Andersen

|Aug 30, 2025
Report on the 2024 international phase II/N-acetyltransferase workshop.

David W Hein

Pageof 6

Frequent Collaborators

3 joint publications

Mariam R Habil

2 joint publications

Samantha M Carlisle

2 joint publications

José A G Agúndez

2 joint publications

Teri E Klein